Gujarat Themis Biosyn Shareholders Approve Director Re-appointment and Related Party Transactions via Postal Ballot

2 min read     Updated on 22 Apr 2026, 07:28 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Gujarat Themis Biosyn Limited shareholders approved two key resolutions through postal ballot voting concluded on April 20, 2026. The re-appointment of Mrs. Kirandeep Madan as Non-Executive Woman Independent Director received 99.9960% approval, while material related party transactions with Themis Medicare Limited were approved with 52.5598% votes in favor. The e-voting process was conducted from March 19-April 17, 2026, through CDSL's platform with CS Ketan Ravindra Shirwadkar as scrutinizer.

powered bylight_fuzz_icon
38368689

*this image is generated using AI for illustrative purposes only.

Gujarat Themis Biosyn Limited has successfully concluded its postal ballot process, with shareholders approving key corporate governance resolutions through electronic voting. The company announced the voting results on April 20, 2026, following the completion of the e-voting period that ran from March 19 to April 17, 2026.

Director Re-appointment Receives Overwhelming Support

The first resolution concerning the re-appointment of Mrs. Kirandeep Madan (DIN: 00686547) as Non-Executive Woman Independent Director received exceptional shareholder support. This special resolution was passed with an overwhelming majority, demonstrating strong confidence in the proposed appointment.

Voting Category: Votes in Favor Votes Against Total Votes Approval Rate
Overall Result: 79330617 3204 79333821 99.9960%
Promoter Group: 76512037 0 76512037 100.0000%
Public Institutions: 1274937 0 1274937 100.0000%
Public Non-Institutions: 1543643 3204 1546847 99.7929%

Related Party Transaction Approval

The second resolution, an ordinary resolution for approval of material related party transactions with Themis Medicare Limited (TML), also secured shareholder approval, though with a narrower margin. The resolution passed with 52.5598% votes in favor.

Voting Details: Votes in Favor Votes Against Approval Rate
Total Valid Votes: 1393892 1258122 52.5598%
Public Institutions: 19555 1255382 1.5338%
Public Non-Institutions: 1374337 2740 99.8010%

Notably, the promoter and promoter group abstained from voting on this resolution due to their interest in the agenda, with 169770 votes declared invalid from this category.

E-voting Process and Compliance

The postal ballot was conducted in compliance with Section 108 and 110 of the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. CS Ketan Ravindra Shirwadkar of KRS AND CO. served as the scrutinizer for the process.

Key process details include:

  • Cut-off Date: Friday, March 13, 2026
  • Notice Dispatch: Wednesday, March 18, 2026
  • E-voting Period: March 19, 2026 (9:00 AM) to April 17, 2026 (5:00 PM)
  • Platform: CDSL's evotingindia.com
  • Advertisement: Published in Western Times (English and Gujarati editions) on March 19, 2026

Shareholder Participation

The voting saw significant participation across different shareholder categories. Out of total outstanding shares of 108965265, a total of 79333821 votes were polled for the first resolution, representing 72.8065% of outstanding shares. For the second resolution, 2652014 votes were polled, representing 2.4338% of outstanding shares.

The company has made the voting results and scrutinizer's report available on its website at www.gtbl.in , ensuring transparency and compliance with regulatory requirements. The successful completion of the postal ballot process reinforces the company's commitment to good corporate governance practices.

Historical Stock Returns for Gujarat Themis Biosyn

1 Day5 Days1 Month6 Months1 Year5 Years
-0.41%+12.35%+35.60%-20.77%+20.86%+47.24%

What strategic initiatives might Mrs. Kirandeep Madan lead as the re-appointed Independent Director to enhance Gujarat Themis Biosyn's corporate governance framework?

How will the approved material related party transactions with Themis Medicare Limited impact Gujarat Themis Biosyn's financial performance and operational synergies in the coming quarters?

What factors contributed to the significant institutional investor opposition (98.5% against) to the related party transaction, and how might this influence future corporate decisions?

like17
dislike

Gujarat Themis Biosyn Limited Opens Special Window for Share Transfer and Dematerialisation Under SEBI Circular

1 min read     Updated on 09 Apr 2026, 03:37 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Gujarat Themis Biosyn Limited has opened a special window from February 05, 2026 to February 04, 2027 for shareholders to re-lodge transfer requests and dematerialise physical shares under SEBI Circular No. HD/38/13/11(2)2026-MIRSDPOD/1/3750/2026. The facility is available for shareholders who sold or purchased shares before April 01, 2019 but had not lodged them for transfer or faced rejection due to document issues. Transferred shares will be credited in demat mode with a one-year lock-in period. The company published notices in Western Times on April 8, 2026, and shareholders can contact MUFG Intime India Private Limited for assistance.

powered bylight_fuzz_icon
37231656

*this image is generated using AI for illustrative purposes only.

Gujarat Themis Biosyn Limited has announced the opening of a special window for shareholders to re-lodge transfer requests and dematerialise physical shares, following regulatory guidelines issued by the Securities and Exchange Board of India (SEBI).

SEBI Circular Implementation

The company has implemented SEBI Circular No. HD/38/13/11(2)2026-MIRSDPOD/1/3750/2026 dated January 30, 2026, which mandates the opening of a special window for transfer and dematerialisation of physical securities. This facility will remain available for one year from February 05, 2026 to February 04, 2027.

Eligibility Criteria and Process

The special window is specifically designed for shareholders who had sold or purchased shares prior to April 01, 2019 and fall into specific categories. The company has provided a detailed eligibility matrix to clarify the applicability:

Lodged for Transfer before April 01, 2019? Original Share Certificate Available? Eligible for Special Window
No (fresh lodgement) Yes Yes (subject to SEBI conditions)
Yes (rejected/returned earlier) Yes No
Yes (was lodged) No No
No (was not lodged) No No

Only requests accompanied by original share certificates, transfer deeds, and supporting documents will be considered under this special window. Shares transferred through this process will be mandatorily credited to the transferee in dematerialised mode only.

Lock-in Period and Restrictions

Shares transferred under this special window will be subject to a lock-in period of one year from the date of registration of transfer. During this period, such shares cannot be transferred, sold, or pledged, ensuring compliance with regulatory requirements.

Public Notice and Communication

Gujarat Themis Biosyn Limited published newspaper notices in Western Times (English) and Western Times (Gujarati) editions on Wednesday, April 8, 2026, to inform shareholders about this opportunity. The company's letter to BSE Limited and National Stock Exchange of India Limited, referenced as GTBL/CS/BSE/NSE/2026-27/02, confirms the publication of these notices.

Contact Information for Shareholders

Shareholders wishing to avail of this special window can contact the company's Registrar & Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India Private Limited), located at C-101, Embassy 247, L.B.S. Marg Vikhroli (West), Mumbai-400083. The SEBI circular is also available on the company's website at www.gtbl.in/news/ for reference.

The company encourages all eligible investors to initiate necessary actions without delay to regularise their pending transfer cases during this one-year window period.

Historical Stock Returns for Gujarat Themis Biosyn

1 Day5 Days1 Month6 Months1 Year5 Years
-0.41%+12.35%+35.60%-20.77%+20.86%+47.24%

Will other listed companies face similar SEBI mandates to open special windows for physical share transfers, potentially creating industry-wide compliance costs?

How might the one-year lock-in period affect Gujarat Themis Biosyn's stock liquidity and trading volumes during 2026-2027?

Could the dematerialization push through special windows accelerate the complete phase-out of physical share certificates across Indian capital markets?

like19
dislike

More News on Gujarat Themis Biosyn

1 Year Returns:+20.86%